Abstract

The reaction of a 100Mo beam at 12 MeV/nucleon impinging on a 4He gas-cell target was performed. The 99Mo alongside other coproduced isotopes were collected after the gas target on an aluminum catcher foil and their respective radioactivities were measured by offline γ-ray analysis. In this contribution, preliminary experimental results which are used to discuss the possibility of optimal large-scale production conditions of the produced radioisotopes are presented.

Highlights

  • Today, radioisotopes are commonly used in medicine, both in diagnosis and therapy

  • A novel method for the production of important medical radioisotopes has been developed at the Cyclotron Institute at Texas A&M University

  • The approach is based on performing the nuclear reaction in inverse kinematics, namely sending a heavy-ion beam of appropriate energy on a light target and isotopes of interest are collected

Read more

Summary

Introduction

A novel method for the production of important medical radioisotopes has been developed at the Cyclotron Institute at Texas A&M University. The approach is based on performing the nuclear reaction in inverse kinematics, namely sending a heavy-ion beam of appropriate energy on a light target and isotopes of interest are collected. The production of the theranostic radionuclide 67Cu (T1/2 = 62 h) was performed through the reaction of a 70Zn beam at 15 MeV/nucleon with a hydrogen gas target [1]. The goal was the study of the production routes for the formation of medically interesting 99Mo (used as 99Mo/99mTc generator) using cyclotron accelerators, as the production in reactors is not enough to cover the world demand [2]. The present work reports on the production routes of 99Mo and other medical radioisotopes using inversekinematics nuclear reactions

Experimental method
Data analysis and results
Findings
Summary
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.